saudi arabia – Retraction Watch

Saudi university dean has 20 retractions in two years

A prolific Saudi pharmacy professor published over 200 papers in the last four years, but in recent months the quality of these papers has come into question.

Nabil Alhakamy, a dean of research and higher education at King AbdulAziz University’s Faculty of Pharmacy, has had more than 20 articles retracted — the most recent of which came on January 30 in AAPS PharmSciTech.

The journal analyzed the images and figures in the article and found three had been published previously and that an outside lab used to collect some of the data had “made a mistake by sending images of other work in the service lab,” according to the retraction notice.

Journal retracts more than 50 studies from Saudi Arabia for faked authorship

The journal Cureus has retracted 56 papers nearly two years after it first began to suspect the works were of dubious lineage.

Cureus – an open access journal founded in 2009 and acquired by Springer Nature in 2022 – slapped 55 of the papers with expressions of concern in April 2022. At that time, at least one author said they didn’t know anything about the work and Cureus noted the “articles were submitted and subsequently published purportedly as an effort coordinated by Imam Abdulrahman Bin Faisal University to ensure all medical interns publish at least one peer-reviewed article in order to qualify for enrollment in a postgraduate residency program as stipulated by The Saudi Commission for Health Specialties (SCFHS).”

At the time, Cureus’ founding editor in chief John Adler told us “The investigation has been frustratingly slow due to the relative unresponsiveness of Saudi gov officials.” Apparently, that remained the case. This week, the journal retracted 56 studies. All of the retraction notices read the same way:

Author objects to “irrelevant reviewers” as journal retracts four papers

Springer Nature’s Scientific Reports has retracted four papers by a researcher in Saudi Arabia who claims “irrelevant reviewers” just couldn’t understand “a new area of statistics.”

Here’s the notice for one of the articles, “Neutrosophic statistical test for counts in climatology,” which appeared in September 2021 and has been cited once, according to Clarivate’s Web of Science:

PLOS ONE retracts a paper first flagged in 2015 — and breaks the 100 retraction barrier for 2019

A team of researchers in Saudi Arabia, led by an ex-pat from Johns Hopkins University, has lost three papers for problems with the images in their articles.

The three retractions pushed the journal — which has become a “major retraction engine” for reasons we explain here and here — over 100 for 2019.

In December, PLOS ONE retrcated three papers by the group, led by Michael DeNiro, of the King Khaled Eye Specialist Hospital in Riyadh. First, the journal retracted a 2011 article, “Inhibition of reactive gliosis prevents neovascular growth in the mouse model of oxygen-induced retinopathy,” the co-authors were Falah H Al-Mohanna and Futwan A Al-Mohanna. According to the retraction notice:

Authors object as “doubtful” data doom dermatology paper

A dermatology journal has retracted a 2017 article by a pair of researchers in Saudi Arabia after receiving a “serious complaint” about the integrity of the data. But the first author of the paper pushed back, saying the move was unjustified.

The article, “Successful use of combined corticosteroids and rituximab in a patient with refractory cutaneous polyarteritis nodosa,” was written by Ibrahim Al-Homood and Mohammad Aljahlan, rheumatologists at King Fahad Medical City in Riyadh and appeared in the Journal of Dermatology & Dermatologic Surgery. It described (with rather grisly pictures) the case of a 25-year-old man with severe leg ulcers that resolved after the described combination therapy.

But at the notice explains, the paper can’t be trusted:

Author loses five recent papers for copying multiple figures, unspecified “overlap”

Two journals have retracted five recent papers by a researcher in Saudi Arabia after discovering extensive overlap, which one journal called plagiarism.

In one retracted paper, all schemes and figures are copies from other publications; in another, more than half of the figures are lifted. The journal that retracted the other three papers did not provide details about the nature of the overlap.

All five retracted papers—originally published within the last 15 months—have the same corresponding author: Soliman Mahmoud Soliman Abdalla, a professor of physics at King Abdulaziz University in Jeddah, Saudi Arabia.

According to a spokesperson for Polymers, readers flagged two papers in July 2017; both were retracted in August.

The spokesperson for Polymers told us that the journal ran the papers through the plagiarism detection software, iThenticate, but found “no significant levels of copied text.” The journal says it missed the overlap because:

Continue reading Author loses five recent papers for copying multiple figures, unspecified “overlap”

First author objects to retraction (his fourth) in chemistry journal

The first author of a 2013 chemistry paper is objecting to his co-authors’ decision to retract the paper, which contains duplicated figures.

We recently encountered a similar scenario with papers by first author Khalid Mahmood. In late 2015, Mahmood lost three papers in the journal ACS Applied Materials & Interfaces over duplicated images. One of the notices also indicated that the figures had “been published elsewhere and identified with different samples” — the same language used in the notice of the most recent retraction, in Journal of Materials Chemistry C.

Mahmood performed the work on the papers at Korea Advanced Institute of Science and Technology (KAIST), along with his two co-authors, Seung Bin Park and Hyung Jin Sung (also co-authors on two of the retracted papers in ACS Applied Materials & Interfaces).

Seung Bin Park, who is dean of the College of Engineering at KAIST, told us: Continue reading First author objects to retraction (his fourth) in chemistry journal

Saudi institution didn’t clear genotyping study

A journal is retracting a paper that sought to validate genotyping techniques after learning the authors skipped a key step.

The authors scanned blood samples from 500 people who visited “the Blood Bank of our institution,” as they note in the abstract, to validate the use of genotyping techniques in the Saudi population. But the authors didn’t obtain the proper clearance from their institution, King Faisal Specialist Hospital, to publish the work.

Here’s the retraction notice for “Genotyping of CYP2C19 polymorphisms and its clinical validation in the ethnic Arab population:”

Continue reading Saudi institution didn’t clear genotyping study

You’ve been dupe’d: Nice data — let’s see them again

As we’ve said before, with hundreds of retractions per year, there are simply too many for us to cover individually.

So from time to time we’ll compile a list of retractions that appeared relatively straightforward, just for record-keeping purposes.

Often, these seemingly straightforward retractions involve duplications, in which authors — accidentally or on purpose — republish their own work elsewhere.

Sometimes journals and authors blame this event on “poor communication,” our first example notes:

Continue reading You’ve been dupe’d: Nice data — let’s see them again

You’ve been dupe’d (again): Do these data look familiar? They are

We can’t keep up with the growing number of retraction notices, so we’ve compiled a list of recent duplications to update our records.

1. Authors don’t always intentionally duplicate their own work, of course. The first paper on our list was retracted after the authors included a figure from a previous paper by accident, according to the publisher: Continue reading You’ve been dupe’d (again): Do these data look familiar? They are

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: